Table 4.

Correlation between asymmetric dimethylarginine (ADMA) and other parameters among each group.

Group	Parameters	ADMA (μmol/l)
		r	P value
Valproate-treated patients	LDL (mg/dl)	0.441	0.001**
	HDL (mg/dl)	−0.076	0.59
	Cholesterol (mg/dl)	−0.091	0.52
	Triglyceride (mg/dl)	0.401	0.003*
	CIMT (mm)	−0.157	0.26
	Homocysteine (μmol/l)	−0.152	0.28
Levatiracetam-treated patients	LDL (mg/dl)	−0.234	0.09
	HDL (mg/dl)	0.217	0.12
	Cholesterol (mg/dl)	−0.242	0.08
	Triglyceride (mg/dl)	−0.126	0.37
	CIMT (mm)	0.039	0.78
	Homocysteine (μmol/l)	0.007	0.96
Multidrug-treated patients	LDL (mg/dl)	0.483	<0.001**
	HDL (mg/dl)	−0.059	0.67
	Cholesterol (mg/dl)	−0.218	0.12
	Triglyceride (mg/dl)	0.098	0.48
	CIMT (mm)	0.204	0.14
	Homocysteine (μmol/l)	0.412	0.002*

*Significant difference. **Highly significant difference.